An Exploratory Study of MT-2990 in Patients With AAV

Clinical trial NCT06196905 · COMPLETED

Trial details

NCT number: NCT06196905
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)

Start date: 2024-06-24
Primary completion: 2026-01-14
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.